ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Search by Abstract Number Results

  • Abstract Number: 0908 • ACR Convergence 2026

    Reframing Strength: Superwoman Schema and Self-Management in Black Women with Systemic Lupus Erythematosus

    Jerik Leung1, Vashti Robinson2, Shacoria Anderson1, Michaela Cotner2, Charmayne Dunlop-Thomas2, Regine Haardoerfer1, Tené Lewis2, S. Sam Lim3 and Cam Escoffery1 Affiliations: 1Emory University, Rollins School of Public Health, Atlanta, GA, 2Emory University, Atlanta, GA, 3Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Black women bear a disproportionate burden of systemic lupus erythematosus (SLE) inequities including poorer quality of life and cardiovascular health. Sociobehavioral mechanisms underlying these…
  • Abstract Number: 0908 • ACR Convergence 2025

    E-602 (Efgitasialase alfa) Enhances Memory B Cell Depletion and Reduces Profibrotic Macrophages via Desialylation in Autoimmune Disease

    Hrishikesh Mehta1, Vijayashree Mysore1, Chih-Hsing Chou1, Lizhi Cao1, Rui Liu2, Tianrui Fan2, Jijun Yuan2, James Broderick1 and Li Peng1, 1Palleon Pharmaceuticals, Waltham, MA, 2Shanghai Henlius Biotech, Shanghai, China (People's Republic)

    Background/Purpose: Abnormal cell surface glycosylation has been observed in various autoimmune diseases, including systemic lupus erythematosus (SLE) and membranous nephropathy. Among these glycan modifications, sialoglycans…
  • Abstract Number: 0908 • ACR Convergence 2024

    Clinical Characteristics of Patients with High SLE-specific and High Multitrait Polygenic Risk – an Investigation of SLE Risk Loci

    Nina Oparina1, Sarah Reid2, Ahmed Sayadi3, Maija-Leena Eloranta4, Martina Frodlund5, Karoline Lerang6, Andreas Jönsen7, Solbritt Rantapaa-Dahlqvist8, Anders Bengtsson7, Anna Rudin9, Øyvind Molberg10, Christopher Sjowall11, Lars Rönnblom4 and Dag Leonard4, 1UU, Uppsala, Sweden, 2Uppsala University, Medical Sciences, Uppsala, Sweden, 3Uppsala, Uppsala, Sweden, 4Uppsala University, Uppsala, Sweden, 5Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden, 6Oslo University, Oslo, Norway, 7Lund University, Lund, Sweden, 8Umeå University, Umeå, Sweden, 9Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, 10Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, 11Linköping University, Linköping, Sweden

    Background/Purpose: Heritability of SLE is high and more than 200 genetically associated SLE risk loci were identified. Part of them  are specific and associate with…
  • Abstract Number: 0908 • ACR Convergence 2023

    Association of Biologic Sex with Glycosphingolipids and the N-glycome in Lupus Nephritis and Renal Mesangial Cell Function

    Tammy Nowling, bethany wolf, Calvin Blaschke, Richard Drake, Sandra Sanchez, Mariia Stefanenko, Mykhailo Fedoriuk, Oleg Palygin, Hongxia Bai and Jessalyn Rodgers, Medical University of South Carolina, Charleston, SC

    Background/Purpose: SLE primarily afflicts women and many SLE patients develop nephritis, a serious complication of lupus. Identification of biomarkers and the pathogenic mechanisms underlying LN…
  • Abstract Number: 0908 • ACR Convergence 2022

    The Association of Cardiovascular Comorbidities with Remission in Rheumatoid Arthritis Patients Undergoing Treatment with Baricitinib and Conventional Synthetic DMARDs: A Post-Hoc Analysis

    Arkady Manning-Bennett1, Ashley Hopkins2, Michael Sorich2, Susanna Proudman3, David Foster1, Ahmad Abuhelwa2 and Michael Wiese1, 1University of South Australia, Adelaide, Australia, 2Flinders University, Adelaide, Australia, 3Rheumatology Unit, Royal Adelaide Hospital, and Discipline of Medicine, University of Adelaide, Adelaide, Australia

    Background/Purpose: Rheumatoid Arthritis (RA) is a chronic autoimmune disease that is characterised by inflammation in the synovium of diarthrodial joints and low-level inflammation in multiple…
  • Abstract Number: 0908 • ACR Convergence 2021

    Evaluation of the Nonsteroidal Anti-Inflammatory Drug-Sparing Effect of Secukinumab in Patients with Ankylosing Spondylitis: Multicenter, Randomised, Double-blind, Phase IV Study

    Uta Kiltz1, Xenofon Baraliakos1, Jan Brandt-Jrgens2, Ulf Wagner3, Sebastian Lieb4, Christian Sieder5, Christian Mann5 and Jürgen Braun1, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Rheumatologische Schwerpunktpraxis, Berlin, Germany, 3Universitätsklinikum Leipzig, Leipzig, Germany, 4Novartis Pharma GmbH, Immunology, Hepatology and Dermatology, Nürnberg, Germany, 5Novartis Pharma GmbH, Nürnberg, Germany

    Background/Purpose: Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat inflammatory back pain in patients (pts) with ankylosing spondylitis (AS). However, an increased risk of side…
  • Abstract Number: 0908 • ACR Convergence 2020

    Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies

    Atul Deodhar1, Philip Mease2, Wolf-Henning Boehncke3, John Tesser4, Elena Schiopu5, Soumya Chakravarty6, Alexa Kollmeier7, Elizabeth Hsia8, Xie Xu9, May Shawi10, Yusang Jiang11, Shihong Sheng11, Prasheen Agarwal11, Joseph Merola12, Iain McInnes13 and Christopher Ritchlin14, 1Oregon Health & Science University, Portland, OR, 2Seattle Rheumatology Associates, P.L.L.C., Seattle, WA, 3Geneva University Hospitals, Geneva, Switzerland, 4Arizona Arthritis & Rheumatology Associates, Phoenix, AZ, 5Michigan Medicine, Ann Arbor, MI, 6Janssen Scientific Affairs, LLC, Horsham, PA, USA and Drexel University College of Medicine, Horsham, PA, 7Janssen Research & Development, LLC, La Jolla, CA, 8Janssen Research & Development, LLC and University of Pennsylvania Medical Center, Spring House, PA, 9Janssen Research & Development, LLC, San Marcos, CA, 10Janssen Global Services, LLC, Toronto, ON, Canada, 11Janssen Research & Development, LLC, Spring House, PA, 12Brigham and Women's Hospital, Harvard Medical School, Newton, MA, 13Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, United Kingdom, 14Department of Medicine, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Guselkumab (GUS), a human monoclonal antibody targeting the IL-23p19-subunit, has shown consistent efficacy in psoriasis pts regardless of body weight/body mass index (BMI).1 GUS…
Search Again

Didn't find what you were looking for? Try the Advanced Search.

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology